AbbVie Financial Statements From 2010 to 2026

ABBV Stock   31.68  0.79  2.56%   
AbbVie CDR's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AbbVie CDR's valuation are provided below:
Market Capitalization
400.9 B
Enterprise Value Revenue
7.7787
Earnings Share
1.3253
AbbVie CDR does not presently have any fundamental signals for analysis.
Check AbbVie CDR financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AbbVie CDR's main balance sheet or income statement drivers, such as , as well as many indicators such as . AbbVie financial statements analysis is a perfect complement when working with AbbVie CDR Valuation or Volatility modules.
  
This module can also supplement various AbbVie CDR Technical models . Check out the analysis of AbbVie CDR Correlation against competitors.

Pair Trading with AbbVie CDR

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AbbVie CDR position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AbbVie CDR will appreciate offsetting losses from the drop in the long position's value.

Moving against AbbVie Stock

  0.42WMT Walmart Inc CDRPairCorr
  0.36AMZN Amazon CDRPairCorr
  0.36AMZN Amazon CDRPairCorr
  0.33GOOG Alphabet CDRPairCorr
  0.33GOOG Alphabet CDRPairCorr
The ability to find closely correlated positions to AbbVie CDR could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AbbVie CDR when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AbbVie CDR - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AbbVie CDR to buy it.
The correlation of AbbVie CDR is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AbbVie CDR moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AbbVie CDR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AbbVie CDR can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in AbbVie Stock

AbbVie CDR financial ratios help investors to determine whether AbbVie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbbVie with respect to the benefits of owning AbbVie CDR security.